Adoption of telemonitoring remains behind the times in many countries, despite convincing health economics and political arguments in its favour. Without doubt, telemonitoring has an important part to play in ensuring quality and availability of healthcare remains high despite the demographic challenges ahead.
In Germany, for example, heart disease treatment costs are currently running at c. €2.7 Billion per annum, with 50/70 % of that cost attributed to hospital admissions.
Global studies provide convincing evidence that telemonitoring helps to significantly reduce admissions, length of stay and repeat critical admissions, thus providing significant cost savings. Thus telemonitoring is a vital element in dealing with growing economic challenges in the healthcare system whilst at the same time improving patient care.